down arrow

Evoq Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0JVD01011
  • NSEID:
  • BSEID: 543500
INR
2.86
0.05 (1.78%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Standalone Half Yearly Results
Sep'24
Sep'23
Sep'22
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Mar 2025 is 0.00% vs -100.00% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Mar 2025 is 205.56% vs -515.38% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Mar 2025 is 62.80% vs 4.09% in Sep 2024

stock-summary

Interest

Growth in half year ended Mar 2025 is 0.00% vs 0.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Mar 2025 has fallen from Sep 2024

Compare Half Yearly Results Of Evoq Remedies With
Markets Mojo
Figures in Rs cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
11.76
4,933.00
-4,921.24
-99.76%
Other Operating Income
0.00
0.00
0.00
Total Operating income
11.76
4,933.00
-4,921.24
-99.76%
Raw Material Cost
0.00
386.36
-386.36
-100.00%
Purchase of Finished goods
12.18
988.27
-976.09
-98.77%
(Increase) / Decrease In Stocks
-0.66
15.23
-15.89
-104.33%
Employee Cost
0.05
1,047.96
-1,047.91
-100.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.80
1,170.95
-1,170.15
-99.93%
Total Expenditure (Excl Depreciation)
12.37
3,608.77
-3,596.40
-99.66%
Operating Profit (PBDIT) excl Other Income
-0.61
1,324.23
-1,324.84
-100.05%
Other Income
2.40
200.59
-198.19
-98.80%
Operating Profit (PBDIT)
1.79
1,524.82
-1,523.03
-99.88%
Interest
0.00
8.18
-8.18
-100.00%
Exceptional Items
0.00
61.23
-61.23
-100.00%
Gross Profit (PBDT)
1.79
1,516.64
-1,514.85
-99.88%
Depreciation
0.04
168.82
-168.78
-99.98%
Profit Before Tax
1.75
1,347.82
-1,346.07
-99.87%
Tax
0.04
261.13
-261.09
-99.98%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
1.71
1,086.69
-1,084.98
-99.84%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
1.71
1,147.92
-1,146.21
-99.85%
Equity Capital
24.90
40.06
-15.16
-37.84%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.69
28.66
-27.97
-97.59%
Diluted Earnings per share
0.69
28.61
-27.92
-97.59%
Operating Profit Margin (Excl OI)
-5.19%
26.84%
0.00
-32.03%
Gross Profit Margin
15.22%
30.74%
0.00
-15.52%
PAT Margin
14.54%
22.03%
0.00
-7.49%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 11.76 Cr
in Mar 2025

Figures in Rs Cr
stock-summary

Growth in half year ended Mar 2025 is 0.00% vs -100.00% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 1.71 Cr
in Mar 2025

Figures in Rs Cr
stock-summary

Growth in half year ended Mar 2025 is 205.56% vs -515.38% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.61 Cr
in Mar 2025

Figures in Rs Cr
stock-summary

Growth in half year ended Mar 2025 is 62.80% vs 4.09% in Sep 2024

Half Yearly - Interest
Markets Mojo
No Interest in the last few periods
stock-summary

Growth in half year ended Mar 2025 is 0.00% vs 0.00% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -5.19%
in Mar 2025

Figures in Rs %
stock-summary

Growth in half year ended Mar 2025 has fallen from Sep 2024